Imaging alpha-synuclein pathology in Parkinson's diseaseOA
Parkinson''s disease(PD)is the second most common neurodegenerative disorder.The clinical manifestations of PD include motor symptoms,such as bradykinesia,resting tremor,rigidity,and nonmotor symptoms,which include disturbances in sleep,gastrointestinal function,and olfaction.PD misdiagnosis rates have been reported to reach approximately 30%,partly owing to the heterogeneity of parkinsonism with non-PD pathologies,and the differential diagnosis of PD from neurodegenerative diseases such as multiple systemic atrophy(MSA)and progressive supranuclear palsy poses another unmet need.
Ruiqing Ni
Institute for Regenerative Medicine,University of Zurich Institute for Biomedical Engineering,ETH Zurich and University of Zurich,Zurich,Switzerland Department of Nuclear Medicine,Inselspital,Bern University Hospital,University of Bern,Bern,Switzerland
医药卫生
neurodegenerative diseasesneurodegenerative disorderalpha synuclein pathologyparkinsons disease pdParkinsons diseaseresting tremorneurodegenerative disorderthebradykinesia
《Neural Regeneration Research》 2026 (4)
P.1566-1567,2
supported by Swiss Center for Applied Human Toxicology(SCAHT AP22-01)(to RN)。
评论